---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-21-005846"
form_type: "8-K"
ticker: "CNBX"
cik: "0001343009"
company_name: "CNBX Pharmaceuticals Inc."
filed_at: "2021-11-19T23:59:59+00:00"
generated_at: "2026-06-28T06:27:59.919733+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cannabics appoints Shaul Yemal to Board as independent director and Audit Committee member

## Summary
- Board expanded to five members; Shaul Yemal appointed as independent director and Audit Committee member.
- Yemal brings transnational finance experience, including roles at Israeli Ministry of Finance and Ministry of Energy.
- Previously CEO of ICL Santiago, Senior VP at ISAL Amlat VC Fund, and catalyst for Oridion Medical's IPO on Swiss exchange.
- No arrangements or understandings with any other person; no related party transactions disclosed.

## SEC filing metadata
- accession: 0001683168-21-005846
- form_type: 8-K
- ticker: CNBX
- cik: 0001343009
- company_name: CNBX Pharmaceuticals Inc.
- filed_at: 2021-11-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1343009/000168316821005846/0001683168-21-005846-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1343009/000168316821005846/cannabics_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-21-005846
- JSON: https://secwatch.observer/filing/0001683168-21-005846.json
- Plain text: https://secwatch.observer/filing/0001683168-21-005846.txt

## Key facts
- Executive change
  Shaul Yemal was appointed as Independent Director at CNBX Pharmaceuticals Inc..
  - Action: appointed
  - Role: Independent Director
  source text: On November 16 th , 2021, the Board of Directors (the “Board”) increased the size of the Board to five (5) members, and appointed Mr. Shaul Yemal to the Board as an Independent Director and as a member of the Audit Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1343009/000168316821005846/0001683168-21-005846-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.